Diagnostic gear maker QIAGEN (QGEN +7.4%) perks up on almost triple normal volume in apparent reaction to unconfirmed reports that Thermo Fisher Scientific (TMO +1.4%) is mulling a bid.
QGEN is clawing back from a four-month selloff that trimmed ~40% off the share price before the recent reversal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.